Dana-Farber Research News 07.01.2026

• by

• July 1, 2026

This Week’s CGT News: Duchenne Gene Therapy Hits Pivotal Mark

REGENXBIO reports phase III AAV data in Duchenne; plus: adenoviral immunotherapy, preconditioning-free CAR-T, in vivo immune programming, and DNA-guided CRISPR

• May 25, 2026

• 7 min

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma

• by Martin Zarba, Dylan O’Sullivan, David Maj, Winson Y. Cheung, Lisa Ludwig, Connor Wells, Evan Ferrier, Razane El Hajj Chehade, Frede Donskov, Marc Eid, Sumanta Kumar Pal, Benoit Beuselinck, Rana R. McKay, Lori Wood, Jae Lyun Lee, Cristina Suárez, Kosuke Takemura, Ignacio Duran, Toni K. Choueiri, Daniel YC Heng

• May 4, 2026

DNER drives glycolytic reprogramming in renal cell carcinoma by activating the JAK2/STAT3 signaling pathway

• by Anrui Li, Jing-wen Xu, Jian-hua Qin, Qi Yuan, Lichen Teng

• May 22, 2026